Amgen Shareholder Anemia Drug Suit To Proceed
A federal judge has shot down Amgen Inc.'s bid to duck out of a shareholder lawsuit alleging the biotech company misled investors by concealing the results of a clinical study involving...To view the full article, register now.
Already a subscriber? Click here to view full article